Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 31Pancreatic Neoplasms 8Colorectal Neoplasms 7Biliary Tract Neoplasms 5Neoplasm Metastasis 4Breast Neoplasms 3Recurrence 2Gastrointestinal Neoplasms 2Carcinoma, Hepatocellular 2Advanced Gastric Cancer 2Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Liver Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Bile Duct Neoplasms 1Advanced Solid Tumors 1Advanced Biliary Tract Cancer 1

Interventions

Sorafenib 5lenvatinib 2ledipasvir, sofosbuvir drug combination 2halofantrine 2atezolizumab 2Liver Transplantation 2Immunotherapy 2Control Groups 2Blood Specimen Collection 2Bevacizumab 2Antibodies 2veliparib 1trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1sintilimab 1rubitecan 1repotrectinib 1pevonedistat 1pembrolizumab 1ozanimod 1linifanib 1genexol-PM 1fluorocholine 1fisogatinib 1ficlatuzumab 1durvalumab 1camrelizumab 1belinostat 1bavituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Diseases × titanium silicide × Clear all
NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Second Military Medical University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡